Temi della conferenza In the context of dramatically increasing food allergy incidence and a breakthrough approval in the field, the Next Generation Food Allergy Drug Development Summit will unite large pharma and innovative biotechs to overcome the unique drug development challenges involved in turning promising food allergy biologics into clinical and commercial realities.
Speakers: Melanie Dispenza, Assistant Professor, John Hopkins Medicine, Matthew Heath, Principal Scientist, Innovation and Product Development, Allergy Therapeutics, and more.
